GlassScriptPhysician profile
Keith Buza
NPI 1639846173
$2,505.30
in general payments reported to CMS, 2019-2025
20 companies · $595 in 2025
The $595 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $260 · 2023: $343 · 2024: $1,307 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336 · Travel and Lodging: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,335.78 |
| Travel and Lodging | $909.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,621.07 | 2022-2025 | Mazor X System, Cd Horizon Spinal System, Prestige LP Cervical Disc System |
| Astrazeneca Pharmaceuticals LP | $191.90 | 2023-2024 | Andexxa |
| Boston Scientific Corporation | $158.63 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Chiesi USA, INC. | $70.50 | 2024-2025 | Cleviprex, Kengreal |
| Servier Pharmaceuticals LLC | $56.10 | 2025 | |
| Stryker Corporation | $48.46 | 2023 | Capri Corpectomy Cage System, Everest Spinal System |
| Janssen Pharmaceuticals, INC | $40.76 | 2022 | |
| Pfizer INC. | $39.93 | 2022 | |
| Orthofix Medical, INC. | $37.84 | 2024 | Spinal-Stim |
| Novartis Pharmaceuticals Corporation | $37.41 | 2022 | |
| Si-Bone, INC. | $26.28 | 2025 | |
| Convatec INC. | $26.03 | 2025 | |
| Abbott Laboratories | $24.53 | 2025 | Eterna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.67 | 2022 | |
| Abbvie INC. | $18.90 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.55 | 2022 | |
| Mylan Specialty L.P. | $17.73 | 2022 | |
| Gilead Sciences, INC. | $16.52 | 2022 | |
| Merck Sharp & Dohme LLC | $16.01 | 2022 | |
| Amgen INC. | $14.48 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Buza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.